Navigation Links
Medicis in Medical News

BioMarin Announces Second Quarter 2009 Financial Results

... June 30, 2009, BioMarin had cash and short and long-term investments totaling $485.3 million. During the quarter, BioMarin made the final payment to medicis of $70.6 million related to the Orapred transaction. "During the quarter, we reported encouraging results from the Phase I PEG-PAL study, initi...

Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation

... to use it. Dr. John L. LeRoy is helping Atlanta-area patients reduce the appearance of fine lines and wrinkles with the new Dysport®, licensed by medicis from French developer Ipsen. Dysport® functions much the same way as BOTOX® injections, and may now be considered one of its main competitors....

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

New Survey Reveals High Expectations for Popular Aesthetic Injections

...linum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, medicis Pharmaceutical Corporation. 2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, medicis Pharmaceutical Corporation. Important Safety Information Dysport...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...d effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by Allergan Medical, and Restylane(R) by medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyaluronic acid fillers; and the lidocaine...

Hyperion Therapeutics Raises $60 Million Series C

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Joseph E. Whitters Joins MyoScience, Inc. Board of Directors

...ns in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and medicis Capital GmbH. Press Contacts: Robert M. Curtis, President and CEO MyoScience, Inc. bcurtis@myoscience.com (650) 474-2600...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble

...omote the Dysport(TM) brand as part of a U.S. sales agreement with the manufacturer, Ipsen. Adding Dysport(TM) to their dermal filler empire positions medicis as a formidable foe to Allergan and their arsenal of beauty treatments (Botox(R) and the Juvederm(R) hyaluronic acid gel fillers). Botox(R) by Al...
Medicis in Medical Technology

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

...al unmet needs and underserved patient populations in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

...enal excretion of phenylacetylglutamine, which is formed from phenylacetic acid and glutamine. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conducti...

RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial

... RADIESSE(R) is a registered trademark of BioForm Medical, Inc. Restylane(R) is a registered trademark of HA North American Sales AB, a subsidiary of medicis Pharmaceutical Corporation. Contact: Adam Gridley 650.286.4025 Vice President, Corporate Development BioForm Medical, Inc. ...
Medicis in Biological Technology

DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania

...e soft-tissue volume loss, thus returning the dermis to its original youthful state. Current marketed fillers include market-leader Restylane, sold by medicis Pharmaceutical, and Radiesse sold by Bioform. "We were very pleased to be selected for an investment by Ben Franklin Technology Partners as a part o...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...SI ) Imclone Systems (Nasdaq: IMCL ) Inverness Medical Innovations (Amex: IMA ) Invitrogen Corp. (Nasdaq: IVGN ) Medarex Inc. (Nasdaq: MEDX ) medicis Pharmaceutical (NYSE: MRX ) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion C...

BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results

...demarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

...s commitments and capitalize on the opportunity presented by our recently announced strategic collaboration with Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation," said Chris Rivera, President and CEO. "This team brings a unique and proven track record of developing, gaining regulator...

Hyperion Therapeutics Secures $40 Million In Series B Round

...confidence in Hyperion and our team," said Chris Rivera, President and CEO of Hyperion. "The funding will allow us to complete the licensing deal with medicis Pharmaceutical Corporation (see press release dated August 28, 2007), build out our management team, advance our clinical trials in UCD and HE, and be...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... trademarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...
Other Tags
(Date:6/19/2013)... 19, 2013 The benefits, NASS ... sauna but the overall experience for the majority of ... health-wise. , Mr Mouw, whose Virgina-based company enjoys an ... statement by saying that the type of sauna is ... number of counterfeit imitations which frankly, can be extremely ...
(Date:6/19/2013)... 2013 Across the globe billions of ... access to the medical advances that benefit developed western ... health care and the necessary aid to help curb ... , Outlook with Ben Kingsley is partnering ... in which these people live and highlight the invaluable ...
(Date:6/19/2013)... Denver, Colorado (PRWEB) June 19, 2013 Daily ... vertical jump training method will be published on ... a preview of the article to inform readers about the ... the declaration made by reporters working at Daily Gossip, the ... Manual Guide . , Hiller has understood during the ...
(Date:6/19/2013)... Are you using Twitter in your marketing campaigns? ... , Social media marketing is a proven and affordable ... Included in your social media campaigns should be Twitter messaging, ... and revenue for your business. , According to Statistic ... Many of these individuals are not just using the service ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Researchers from ... demonstrated several new studies at ENDO 2013, ... from June 15-18 in San Francisco.     , Mount Sinai ... as the role of prostastic acid phosphatase (PAP) in ... can stimulate the thyroid gland; revealed the prevalence of ...
Breaking Medicine News(10 mins):Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7
(Date:6/19/2013)... published in the journal Polar Biology, researchers report using DNA ... be a new type of killer whale ( Orcinus orca ... killer whales stranded on a New Zealand beach and a ... also taken but it was almost 50 years before this ... white eye-patch and bulbous forehead, was documented alive in the ...
(Date:6/19/2013)... the most potent physiological anabolic agent for tissue-building ... of lipids, protein and carbohydrates, and inhibiting their ... also plays a major role in stimulating glucose ... metabolized and removed from the blood following meals. ... mechanisms by which insulin regulates glucose uptake in ...
(Date:6/19/2013)... Midwest are expected to contribute to a very large ... according to a University of Michigan ecologist and colleagues ... for the Chesapeake Bay. , The Gulf forecast, one ... Administration, calls for an oxygen-depleted, or hypoxic, region of ... it among the 10 largest on record. , The ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4
Other Contents